CRSP - CRISPR Therapeutics AG

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 69.15

Open

$ 67.55

Bid

$ 67.40 x 10

Ask

$ 69.50 x 101

Day's Range

$ 67.00 - $ 69.57

52 Week Range

$ 30.04 - $ 78.48

Volume

2,006,969

Average Volume

Market Cap

6.29B

Beta (5Y Monthly)

$ 1.37

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-04-2025	06-30-2025	10-Q
2	05-06-2025	03-31-2025	10-Q
3	02-11-2025	12-31-2024	10-K
4	11-05-2024	09-30-2024	10-Q
5	08-05-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	02-21-2024	12-31-2023	10-K
8	11-06-2023	09-30-2023	10-Q
9	08-07-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	02-21-2023	12-31-2022	10-K
12	11-01-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	02-15-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	07-29-2021	06-30-2021	10-Q
18	04-27-2021	03-31-2021	10-Q
19	02-16-2021	12-31-2020	10-K
20	10-28-2020	09-30-2020	10-Q
21	07-27-2020	06-30-2020	10-Q
22	04-28-2020	03-31-2020	10-Q
23	02-12-2020	12-31-2019	10-K
24	10-28-2019	09-30-2019	10-Q
25	07-29-2019	06-30-2019	10-Q
26	04-29-2019	03-31-2019	10-Q
27	02-25-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	03-08-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-11-2017	03-31-2017	10-Q
35	03-10-2017	12-31-2016	10-K
36	11-22-2016	09-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

B of A Securities Maintains Buy on CRISPR ...
10/17/2025 11:16:40

B of A Securities analyst Geoff Meacham maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and raises the price target f...

Needham Reiterates Buy on CRISPR Therapeut...
10/10/2025 15:04:22

Needham analyst Gil Blum reiterates CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and maintains $81 price target.

CRISPR Therapeutics Reports New Preclinica...
10/10/2025 12:13:27

-Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profil...

10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

10 Health Care Stocks Whale Activity In To...
10/03/2025 17:35:44

CRISPR Therapeutics To Present Preclinical...
10/01/2025 12:04:16

HC Wainwright & Co. Reiterates Buy on CRIS...
09/23/2025 10:59:59

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and maintains $80...

CRISPR Therapeutics And Sirius Therapeutic...
09/22/2025 12:34:00

CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for seri...

my-top-biotech-stock-picks-and-portfolio-strategy-for-the-next-3-10-years

My Top Biotech Stock Picks And Portfolio S...
09/18/2025 17:10:48

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of...

JP Morgan Initiates Coverage On CRISPR The...
09/18/2025 10:55:54

JP Morgan analyst Brian Cheng initiates coverage on CRISPR Therapeutics (NASDAQ:CRSP) with a Overweight rating and announces...

How Is The Market Feeling About CRISPR The...
09/12/2025 18:00:46

10 Health Care Stocks Whale Activity In To...
09/02/2025 17:35:29

Peering Into CRISPR Therapeutics's Recent ...
08/22/2025 13:00:48

cathie-woods-arkk-is-beating-big-tech-like-its-2020-again--but-with-a-twist

Cathie Wood's ARKK Is Beating Big Tech Lik...
08/19/2025 15:40:03

Cathie Wood's ARK Innovation ETF is outperforming tech market again in 2025, driven by AI breakthroughs and the return of i...

cathie-woods-top-10-stock-picks-unpacking-ark-funds-innovation-picks-for-the-next-decade

Cathie Wood's Top 10 Stock Picks: Unpackin...
08/14/2025 17:02:25

Ark Invest has six main ETFs with several around for more than 10 years. A look at the top 10 holdings across the six funds and...

HC Wainwright & Co. Maintains Buy on CRISP...
08/07/2025 11:54:08

HC Wainwright & Co. analyst Mitchell Kapoor maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and raises the price ...

Barclays Maintains Equal-Weight on CRISPR ...
08/06/2025 14:11:44

Barclays analyst Gena Wang maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Equal-Weight and raises the price target from ...

Cathie Wood's Ark Dumps Block Stock Worth ...
08/06/2025 01:48:06

Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.

Chardan Capital Maintains Buy on CRISPR Th...
08/05/2025 22:19:41

Chardan Capital analyst Geulah Livshits maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and maintains $82 price target.

RBC Capital Maintains Sector Perform on CR...
08/05/2025 13:15:50

RBC Capital analyst Luca Issi maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Sector Perform and raises the price target ...